Sanofi opens new vaccine R&D site in Canada
Sanofi Pasteur has opened a new centre in Canada in an effort to streamline its global vaccine R&D operations.
Sanofi Pasteur has opened a new centre in Canada in an effort to streamline its global vaccine R&D operations.
India’s DCGI has banned CRO Axis Clinicals from conducting bio-availability and bio-equivalence studies at its facility in Miyapur, Hyderabad.
UK-based contract testing service BioOutsource has received GLP certification from the Medicines and Healthcare products Regulatory Agency (MHRA).
US CRO Celerion gained Brazilian National Health Surveillance Agency (Agência Nacional de Vigilancia Sanitaria ANVISA) approval for its bioanalysis labs in Lincoln, Nebraska and in Belfast, Northern Ireland.
Australia’s CSL Biotherapies has received a warning letter from the US FDA for GMP deviations at its vaccine production plant in Parkville, Victoria.
Gerresheimer will expand its pharmaceutical packaging plant in the Czech Republic to meet growing demand for plastic systems and to further expand a key training hub.